Fexofenadine is a second-generation H1 antihistamine that does not typically have a direct therapeutic role in treating Cluster Headache, as its primary mechanism of action involves blocking histamine receptors without significant impact on the underlying pathophysiology of cluster headaches. While it may provide some symptomatic relief by reducing inflammatory responses, it is not considered a primary or recommended treatment for this specific neurological pain syndrome.